Stockreport

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

NovaBay Pharmaceuticals, Inc.  (NBY) 
NASDAQ:AMEX Investor Relations: novabay.com/investors
PDF Online Avenova® sales increase 14% for the quarter and 19% for the nine monthsSales and marketing expenses declined 25% for the quarter and 18% for the nine months refle [Read more]